Local biotech Aardvark Therapeutics made its debut on the public market this month, making it San Diego’s first life science ...

Bluejay Therapeutics, a drug developer focused on serious viral and liver diseases, is considering a US initial public offering, according to people familiar with the matter.

The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in ...

Biotech stocks may be primed for a long-term bull run. Learn why IBB, XBI, and macro trends like rate cuts make biotech an ...

This was the fourth biotech IPO of 2025, and the company raised around $219 million in its IPO, intended to advance its cystic fibrosis treatments. That is a market dominated Vertex ...

Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders.

It means the IPO should bring in gross proceeds of $ ... day option to buy a further 883,200 shares at the same price. The biotech’s pipeline is headed up by ARD-101, a bitter taste receptor ...

This week, Germany-based Anbio Biotechnology (NNNN) is expected to raise capital during its IPO. "NNNN is seeking US public capital market investment as it aims to commercialize its in vitro ...

Kirkland, Wash.-based Kestra Medical Technologies is aiming to raise about $150 million in its initial public offering, ...

Belrise Industries aims to raise Rs 2,150 crore, while Paramesu Biotech plans to mop up Rs 600 crore through the public issue ...

Paramesu Biotechs IPO aims to raise ₹600 crore for expansion and debt repayment, showcasing strong financial performance and ...